Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.53 Billion | USD 2.26 Billion | 5.04% | 2023 |
The global D-dimer testing market size was worth around USD 1.53 billion in 2023 and is predicted to grow to around USD 2.26 billion by 2032 with a compound annual growth rate (CAGR) of roughly 5.04% between 2023 and 2030.
D-Dimer is a protein fragment synthesized when a clot dissolves in the body. It is very difficult to detect these products in the body unless there is a breakdown of the blood clot.
D-dimer is a kind of test to examine or detect the presence of D-dimer in the blood. The test is useful for the detection of various diseases like pulmonary embolism, disseminated intravascular coagulation, deep vein thrombosis, stroke, and many more.
There is a surge in the demand of the D-dimer test owing to its cost-effective and accurate test results. One of the major factors that boost the global D-Dimer market growth is the non-intervention of radiology aspects in the test.
The growing prevalence of D-dimer in females at a young age due to the stress and burden of associated illness or disorder is expected to boost market growth. There is a gradual shift to next-generation sequencing and point of care D-dimer test. This shift is boosting demand and market growth over the forecast year. This shift can be contributed to the point of care (POC) solution implementation that significantly reduced the patient stay and waiting time. It aids in faster diagnosis and enhanced patient experience. All of these factors tend to boost the growth of the global D-Dimer market. Moreover, the increase in venous thromboembolism rates coupled with the cardiovascular and pulmonary diseases that become life-threatening due to blood clotting has increased the demand for D-dimer tests.
Advanced research studies show that high levels of D-dimer serves as a good marker in many critical conditions like HIV filtration, atrial fibrillation, coronary artery disease, and many more. The D-dimer also assists in the risk assessment of disease like acute pancreatitis.
The global D-dimer market can be segmented into product, method, test, end-use, application, and region.
By product, the market can be segmented into reagents & consumable and analyzers.
By method, the market can be segmented into fluorescence immunoassay, latex enhanced, immunoturbidimetric, and enzyme-linked immunosorbent assay. Enzyme-linked immunosorbent assay segment holds the largest share in the global D-dimer market. The emergence of automated tests and highly sensitive ELISA assays has won over the traditional ELISA assays. This shift will drive the market growth significantly over the forecast period.
By end-use, the market can be segmented into diagnostic centers, academic & research institutes, hospitals, and others. The hospital segment is dominating the market globally with the largest share in the market.
By application, the market can be segmented into disseminated intravascular coagulation, pulmonary embolism, and deep vein thrombosis. Deep vein thrombosis holds the largest share in the market.
By test, the market can be segmented into point of care tests and clinical laboratory tests. The clinical lab tests segment is expanding globally with the largest market share.
Report Attributes | Report Details |
---|---|
Report Name | D-dimer Testing Market Research Report |
Market Size in 2023 | USD 1.53 Billion |
Market Forecast in 2032 | USD 2.26 Billion |
Growth Rate | CAGR of 5.04% |
Number of Pages | 215 |
Key Companies Covered | Sekisui Diagnostics, Biomedica Diagnostics, Diazyme Laboratories, Inc., Siemen Healthineers, F. Hoffmann-La Roche Ltd., WERFEN, biomérieux SA, Quidel Corporation, and Thermo Fisher Scientific Inc. |
Segments Covered | By Product, By Test, By Method, By Application, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America holds the largest share in the global D-Dimer market. The surge in the publications involving D-dimer applications is responsible for the regional growth of the market.
Asia Pacific is expected to witness a significant increase in growth rates over the forecast years. Due to the government guidelines, the pathology manuals use D-dimer tests to facilitate better interpretation of results and thus boost the growth of the regional market.
The global D-dimer testing market is led by players like:
By Product
By Test
By Method
By End-Use
By Application
Global D-dimer Testing Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
The diagnostic blood test known as D-dimer testing quantifies the concentration of D-dimer in the bloodstream. D-dimer, a fibrin degradation product, is a protein fragment of minimal size that is generated during the process of blood clot disintegration. A protein that contributes to the formation of blood clotting is fibrin.
The demand for D-dimer testing may be influenced by the prevalence of conditions linked to anomalous blood clotting, including pulmonary embolism (PE), deep vein thrombosis (DVT), and disseminated intravascular coagulation (DIC). Frequently, the risk of developing thrombotic disorders increases with age. The rising average age of the world's population increases the probability that an individual will necessitate D-dimer testing, thereby stimulating market expansion.
The global D-dimer testing market size was worth around USD 1.53 billion in 2023 and is predicted to grow to around USD 2.26 billion by 2032.
The global D-dimer testing market with a compound annual growth rate (CAGR) of roughly 5.04% between 2023 and 2032.
North America holds the largest share in the global D-Dimer market. The surge in the publications involving D-dimer applications is responsible for the regional growth of the market. Asia Pacific is expected to witness a significant increase in growth rates over the forecast years. Due to the government guidelines, the pathology manuals use D-dimer tests to facilitate better interpretation of results and thus boost the growth of the regional market.
Some of the significant leaders in the global D-dimer market are Sekisui Diagnostics, Biomedica Diagnostics, Diazyme Laboratories, Inc., Siemen Healthineers, F. Hoffmann-La Roche Ltd., WERFEN, biomérieux SA, Quidel Corporation, and Thermo Fisher Scientific Inc.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed